15-03-2023, 18:01

ObsEva Announces Progress Towards its Plans to Consolidate

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 15, 2023 – ObsEva SA
Globe Newswire15-03-2023, 18:01
15-03-2023, 17:59

Kingsoft Cloud to Report Fourth Quarter and Fiscal Year

BEIJING, March 15, 2023 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft
Globe Newswire15-03-2023, 17:59
15-03-2023, 17:56

RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full

Conference call to be held Monday, March 20, 2023, at 8:30 a.m. ET...
Globe Newswire15-03-2023, 17:56
15-03-2023, 17:03

Array Technologies, Inc. Announces Updated Earnings Release

ALBUQUERQUE, N.M., March 15, 2023 (GLOBE NEWSWIRE) -- Today Array Technologies (NASDAQ: ARRY) (“Array” or “the
Globe Newswire15-03-2023, 17:03
15-03-2023, 07:18

Tango Therapeutics to Highlight Preclinical Data on

BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced the acceptance of
Globe Newswire15-03-2023, 07:18
15-03-2023, 05:27

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further
Globe Newswire15-03-2023, 05:27
15-03-2023, 05:12

Kinnate Biopharma Inc. to Report First Clinical Data for

Company has initiated enrollment of patients into the monotherapy expansion cohorts Company to host a virtual investor
Globe Newswire15-03-2023, 05:12
15-03-2023, 05:09

CRISPR Therapeutics to Present at the American Association

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a
Globe Newswire15-03-2023, 05:09
15-03-2023, 04:41

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine
Globe Newswire15-03-2023, 04:41
15-03-2023, 03:58

Nurix Therapeutics Announces Presentations at the American

Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948...
Globe Newswire15-03-2023, 03:58
15-03-2023, 03:57

Sana Biotechnology Announces the Acceptance of Four

Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of
Globe Newswire15-03-2023, 03:57
15-03-2023, 03:39

Cullinan Oncology to Present New Preclinical Data for

CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with
Globe Newswire15-03-2023, 03:39